Literature DB >> 12667687

A protocol for 'enhanced pepsin digestion': a step by step method for obtaining pure antibody fragments in high yield from serum.

R G A Jones1, J Landon.   

Abstract

The digestion of ovine antiserum under acidic conditions (pH 3.5) by pepsin is highly effective at reducing all unwanted serum components to low molecular weight (< or =13 kDa) fragments while leaving the approximately 100-kDa F(ab')(2) intact. The pH is then raised to 6 to stop further digestion and the reaction mixture centrifuged or filtered to remove any insoluble contaminants. Next, unwanted low molecular weight fragments are removed by diafiltration with a 30-kDa nominal molecular weight cut-off membrane leaving an F(ab')(2) solution contaminated only with some pepsin and a small amount of the aggregated low molecular weight fragments. Material of this purity is suitable for many applications but, since all the contaminants are highly acidic, they can be easily removed by passage down an anion-exchange column to yield F(ab')(2) that is essentially free from pepsin and aggregates with a typical purity of over 96% and yields of 16-19 g/l serum. When an antivenom was processed, approximately 78% of the original serum's toxin neutralising capacity was recovered. This simple, high yield protocol for processing serum to highly purified F(ab')(2) avoids the need for an initial or any subsequent salt precipitation step and can be utilised for either bench or large scale production. If required, a mild reducing agent may be used finally to create Fab fragments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667687     DOI: 10.1016/s0022-1759(03)00005-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Transferred antigen-specific T(H)17 but not T(H)1 cells induce crescentic glomerulonephritis in mice.

Authors:  Calogero Tulone; Angela Giorgini; Simon Freeley; Alice Coughlan; Michael Gregory Robson
Journal:  Am J Pathol       Date:  2011-10-08       Impact factor: 4.307

2.  The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics.

Authors:  Sami El Khatib; Mohamed Salla
Journal:  Leuk Res Rep       Date:  2022-06-27

3.  Evaluation of Cellular Targeting by Fab' vs Full-Length Antibodies in Antibody-Nanoparticle Conjugates (ANCs) Using CD4 T-cells.

Authors:  Khushboo Singh; Mine Canakci; Pintu Kanjilal; Natalie Williams; Sudarvili Shanthalingam; Barbara A Osborne; S Thayumanavan
Journal:  Bioconjug Chem       Date:  2022-02-09       Impact factor: 6.069

4.  Streamlined downstream process for efficient and sustainable (Fab')2 antivenom preparation.

Authors:  Tihana Kurtović; Marija Brgles; Maja Lang Balija; Stephanie Steinberger; Dora Sviben; Martina Marchetti-Deschmann; Beata Halassy
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-07-27

5.  Production of native bispecific antibodies in rabbits.

Authors:  Wei Wang; Ruihuan Xu; Jinming Li
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

6.  Prevention and treatment of influenza with hyperimmune bovine colostrum antibody.

Authors:  Wy Ching Ng; Victor Wong; Brian Muller; Grant Rawlin; Lorena E Brown
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

7.  Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.

Authors:  Mehmet Özen; Soner Yılmaz; Tülin Özkan; Yeşim Özer; Aliye Aysel Pekel; Asuman Sunguroğlu; Günhan Gürman; Önder Arslan
Journal:  Turk J Haematol       Date:  2017-05-23       Impact factor: 1.831

8.  Refinement strategy for antivenom preparation of high yield and quality.

Authors:  Tihana Kurtović; Maja Lang Balija; Marija Brgles; Dora Sviben; Monika Tunjić; Hrvoje Cajner; Martina Marchetti-Deschmann; Günter Allmaier; Beata Halassy
Journal:  PLoS Negl Trop Dis       Date:  2019-06-17

9.  Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.

Authors:  Jiahai Lu; Zhongmin Guo; Xinghua Pan; Guoling Wang; Dingmei Zhang; Yanbin Li; Bingyan Tan; Liping Ouyang; Xinbing Yu
Journal:  Respir Res       Date:  2006-03-23

10.  Substrate specificity of healthy human sera IgG antibodies with peroxidase and oxydoreductase activities.

Authors:  Anna S Tolmacheva; Evgeny A Ermakov; Valentina N Buneva; Georgy A Nevinsky
Journal:  R Soc Open Sci       Date:  2018-01-31       Impact factor: 2.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.